Covance commences regular way trading on NYSE.PRINCETON, N.J.--(BUSINESS WIRE)--Jan. 14, 1997--Covance Inc. (NYSE NYSE See: New York Stock Exchange :CVD CVD Cardiovascular disease, see there ), formerly Corning Pharmaceutical Services Inc., today announced the commencement of regular-way trading on the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. . The Company will trade under the ticker symbol Ticker Symbol An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors CVD. Covance was spun-off by Corning Incorporated Corning Incorporated NYSE: GLW is an American manufacturer of glass, ceramics and related materials, primarily for industrial and scientific applications. The company was known until 1989 as Corning Glass Works. on Dec. 31, 1996. Covance, with headquarters in Princeton, N.J., is one of the world's largest and most comprehensive biopharmaceutical development service companies, with 1995 revenues of more than $400 million, operations in more than 15 countries, and currently more than 5,000 employees worldwide. Covance is dedicated to providing preclinical, health economics, central laboratory, biomanufacturing, clinical packaging and clinical and periapproval services to the world's pharmaceutical, biotechnology and medical device companies. CONTACT: Covance Inc., Princeton Parag Bhansali, (Investors), 609/452-4953 Andrew MacKnight, (Media), 609/452-4014 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion